Adapalene gel 1% cause of hair loss?
    6/27/2023

    New to Minoxidil? There is a guide in the encyclopedia. Read the guide →
    At a glance
    In this treatment experience post, the primary subjects mentioned are
    💧 Adapalene (topical) 1% every night 4 months
    💧 Minoxidil (topical) 5% once a day 1 year
    💧 Minoxidil/Finasteride (topical) Finasteride 0.1% 1 month
    💧 Revita Shampoo (topical) as needed
    the tone is 😐 neutral with great results.

    Other terms

    A user experienced hair thinning after using Adapalene gel 1% for skin care, suspecting it contributed to hair loss alongside depression and anxiety. They stopped using Adapalene and switched to a Minoxidil/Finasteride formula, noticing hair improvement, while others in the conversation doubted Adapalene's impact on hair loss.
    View this post in the Community →

    Similar Community Posts Join

    5 / 5 results

    Related Research

    6 / 6 results

      research Nanotechnology advances for hair loss

      27 citations , August 2018 in “Therapeutic Delivery”
      In this study, researchers reviewed recent advances in using nanoencapsulation technology to improve the pharmacological treatment of alopecia, suggesting its potential to enhance drug delivery and reduce adverse effects compared to conventional methods.

      research Common Dermatologic Conditions

      14 citations , April 2014 in “Medical Clinics of North America”
      This review discusses common skin conditions in primary care settings and provides guidance on differential diagnoses and selecting appropriate topical treatments, but it reports no new clinical results.

      research Dermatological problems of the puberty

      18 citations , January 2013 in “Postepy Dermatologii I Alergologii”
      This article discusses the common dermatological issues in adolescence linked to hormone fluctuations, such as acne and excessive sweating, and reports no new clinical results.

      research Therapies

      August 2010 in “The Journal of Dermatology”
      The document concludes that low-dose acne treatment is most suitable for moderate acne, with high patient satisfaction and low relapse rates.